1998PubMedRequires access

[Detection of serum hepatitis B virus DNA in patients with various chronic liver diseases].

Zhenhua Zhou, Chaojie Liu, Jie Wu Yang

Open publisher page 0 citations

Abstract

With established competitive polymerase chain reaction (PCR) method, serum HBV DNA concentration was determined in 125 patients with primary hepatic carcinoma(n = 38), liver cirrhosis (n = 36) and chronic hepatitis (n = 51) with different serum HBV immunological markers. The results showed that: (1) No significant variation of HBV DNA concentration was detected in patients with different chronic liver diseases; (2) About one third of the examined patients whose five serum HBV markers were negative and anti-HBs were positive showed low level of viral replications; (3) The total concentration of HBV DNA in the patients with positive HBeAg were significantly higher than that in patients positive for anti-HBe, but also found a high HBV DNA concentration in some of the latter. It suggests that the manner of viral replication were not correlated with the period of the chronic liver disease. So HBV replicative status may not be completely determined only by seroconvertion of HBeAg to anti-HBe.

About this research paper

What this paper is about

With established competitive polymerase chain reaction (PCR) method, serum HBV DNA concentration was determined in 125 patients with primary hepatic carcinoma(n = 38), liver cirrhosis (n = 36) and chronic hepatitis (n = 51) with different serum HBV immunological markers. The results showed that: (1) No significant variation of HBV DNA concentration was detected in patients with different chronic liver diseases; (2) About one third of the examined patients whose five serum HBV markers were negative and anti-HBs were positive showed low level of viral replications; (3) The total concentration of HBV DNA in the patients with positive HBeAg were significantly higher than that in patients positive for anti-HBe, but also found a high HBV DNA concentration in some of the latter. It suggests that the manner of viral replication were not correlated with the period of the chronic liver disease. So HBV replicative status may not be completely determined only by seroconvertion of HBeAg to anti-HBe.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

With established competitive polymerase chain reaction (PCR) method, serum HBV DNA concentration was determined in 125 patients with primary hepatic carcinoma(n = 38), liver cirrhosis (n = 36) and chronic hepatitis (n = 51) with different serum HBV immunological markers. The results showed that: (1) No significant variation of HBV DNA concentration was detected in patients with different chronic liver diseases; (2) About one third of the examined patients whose five serum HBV markers were negative and anti-HBs were positive showed low level of viral replications; (3) The total concentration of HBV DNA in the patients with positive HBeAg were significantly higher than that in patients positive for anti-HBe, but also found a high HBV DNA concentration in some of the latter. It suggests that the manner of viral replication were not correlated with the period of the chronic liver disease. So HBV replicative status may not be completely determined only by seroconvertion of HBeAg to anti-HBe.

Key concepts: HBeAg, Cirrhosis, Hepatocellular carcinoma, Hepatitis B virus, Liver disease, Medicine, Chronic hepatitis, Virology

Related papers

Back to paper searchBrowse research topicsOriginal source
[Detection of serum hepatitis B virus DNA in patients with various chronic liver diseases]. — Research Paper | ScholarLens